Hyoscyamine, atropine, scopolamine, and phenobarbital vs Deferasirox

Interacting Drugs
Hyoscyamine, atropine, scopolamine, and phenobarbital
vs
Deferasirox
Security Level
Moderate, Consider therapy modification
Mechanism
Deferasirox: PHENobarbital may decrease the serum concentration of Deferasirox.
Management
Avoid combination when possible; if the combination must be used, consider an increase in initial deferasirox dose to 30 mg/kg, and monitor serum ferritin concentrations/clinical responses to guide further dosing.

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Hyoscyamine, atropine, scopolamine, and phenobarbital vs Deferasirox